Literature DB >> 30968371

Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.

Chaomin Zhou1, Lin Zhan2, Jing Yuan1, Xiaoya Tong1, Yanzhe Peng1, Yan Zha3.   

Abstract

PURPOSE: We aimed to compare the predictive ability of the anthropometric indices reflecting general, central and visceral obesity for identification of metabolic syndrome (MetS) in maintenance hemodialysis (MHD) patients.
METHODS: A multicenter, cross-sectional study that consisted of 1603 adult MHD patients (54.6 ± 16 years) was conducted in Guizhou Province, Southwest China. Eight anthropometric obesity indexes including body mass index (BMI), waist circumference (WC), waist-height ratio (WHtR), conicity index (Ci) and visceral adiposity index (VAI), lipid accumulation product (LAP), a body shape index (ABSI) and body roundness index (BRI) were recorded. MetS was defined based on the criteria of the International Diabetes Federation. Participants were categorized into four groups according to quartiles of different obesity indices. Binary logistic regression analyses were used to evaluate the associations between the eight obesity parameters and MetS. Receiver operator curve (ROC) analyses were used to identify the best predictor of MetS.
RESULTS: The eight anthropometric obesity indexes were independently associated with MetS risk, even after adjustment for age, sex, educational status and history of smoking. The ROC analysis revealed that all the eight obesity indices included in the study were able to discriminate MetS [all area under the ROC curves (AUCs) > 0.6, P < 0.05]. LAP showed the highest AUC and according to the maximum Youden indexes, the cut off values for men and women were 27.29 and 36.45, respectively. The AUCs of LAP, VAI, ABSI, BRI, WC, WHtR, Ci and BMI were 0.88, 0.87, 0.60, 0.78, 0.79, 0.78, 0.69 and 0.76 for men, and 0.87, 0.85, 0.65, 0.79, 0.81, 0.79, 0.73 and 0.76 for women, respectively. There was no significant difference in the AUC value between LAP and VAI, BRI/WHtR and BMI in men and between BRI/WHtR and BMI in women. The AUC value for WHtR was equal to that for BRI in identifying MetS.
CONCLUSIONS: Visceral obesity marker LAP followed by VAI was the most effective predictor of MetS while ABSI followed by CI was the weakest indicator for the screening of MetS in MHD patients. BRI could be an alternative obesity measure to WHtR in assessment of MetS. LAP may be a simple and useful screening tool to identify individuals at high risk of MetS particularly in middle-aged and elderly Chinese MHD patients. LEVEL OF EVIDENCE: Level V, descriptive study.

Entities:  

Keywords:  Hemodialysis; Metabolic syndrome; Obesity

Mesh:

Year:  2019        PMID: 30968371     DOI: 10.1007/s40519-019-00678-9

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  10 in total

1.  Comparison of Inflammatory Markers in the Diagnosis of Metabolic Syndrome in Hemodialysis Patients: A Multicenter Observational Study.

Authors:  Yinjiao Zhao; Hui Zhang; Peiyu Song; Xiaoyu Chen; Peipei Han; Chenghu Fang; Chen Yu; Qi Guo
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-04       Impact factor: 3.249

2.  Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program.

Authors:  Neda Rabiei; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Mehdi Sadeghian; Saba Maleki Birjandi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-28

3.  Association Between Four Anthropometric Indexes and Metabolic Syndrome in US Adults.

Authors:  Yaling Li; Rui Zheng; Shuting Li; Ruyi Cai; Feihua Ni; Huiyan Zheng; Ruying Hu; Ting Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-24       Impact factor: 6.055

4.  Comparisons of conventional and novel anthropometric obesity indices to predict metabolic syndrome among vegetarians in Malaysia.

Authors:  Yuan Kei Ching; Yit Siew Chin; Mahenderan Appukutty; Wan Ying Gan; Yoke Mun Chan
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

5.  Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes.

Authors:  Xintong Guo; Qinpei Ding; Min Liang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-30       Impact factor: 3.168

6.  Anti-Müllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS.

Authors:  Xiying Zeng; Yinxiang Huang; Mulin Zhang; Yun Chen; Jiawen Ye; Yan Han; Danyan Ma; Xin Zheng; Xiaohong Yan; Changqin Liu
Journal:  Endocr Connect       Date:  2022-01-10       Impact factor: 3.335

7.  Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients.

Authors:  Chaomin Zhou; Yanzhe Peng; Wenyong Jiang; Jing Yuan; Yan Zha
Journal:  BMC Endocr Disord       Date:  2021-12-19       Impact factor: 2.763

8.  Using noninvasive anthropometric indices to develop and validate a predictive model for metabolic syndrome in Chinese adults: a nationwide study.

Authors:  Jie Zhou; Qiuhe Ji; Qian Xu; Li Wang; Jie Ming; Hongwei Cao; Tao Liu; Xinwen Yu; Yuanyuan Bai; Shengru Liang; Ruofan Hu; Li Wang; Changsheng Chen
Journal:  BMC Endocr Disord       Date:  2022-03-03       Impact factor: 2.763

9.  Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China.

Authors:  Hangtian Li; Qian Wang; Jianghua Ke; Wenwen Lin; Yayong Luo; Jin Yao; Weiguang Zhang; Li Zhang; Shuwei Duan; Zheyi Dong; Xiangmei Chen
Journal:  Nutrients       Date:  2022-03-23       Impact factor: 5.717

10.  Comparison of obesity-related indicators for identifying metabolic syndrome among normal-weight adults in rural Xinjiang, China.

Authors:  Le-Yao Jian; Shu-Xia Guo; Ru-Lin Ma; Jia He; Dong-Sheng Rui; Yu-Song Ding; Yu Li; Xue-Ying Sun; Yi-Dan Mao; Xin He; Sheng-Yu Liao; Heng Guo
Journal:  BMC Public Health       Date:  2022-09-12       Impact factor: 4.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.